Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01058291Phase 3Completed
A Phase 3 trial of apomine in Parkinson's disease (PD), sponsored by Kyowa Kirin. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01058291.